← Back to Search

Placebo

VisionPure Dietary Supplement for Eye Health

N/A
Waitlist Available
Led By Jacob Wilson, Ph.D.
Research Sponsored by Applied Science & Performance Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0, day 60
Awards & highlights

Study Summary

This trial is testing a dietary supplement (VisionPure) containing fish oil, lutein, zeaxanthin, and vitamin D to see if it helps maintain eye and cognitive health, and protects against blue light exposure. 16 people will be recruited and given either the supplement or a placebo for 60 days, after which they will have their eyesight and cognitive function tested.

Eligible Conditions
  • Eye Health
  • Vision
  • Cognitive Functioning

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0, day 60
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0, day 60 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Central Retinal Thickness
Change in Ganglion Cell Complex Thickness
Change in Intraocular Pressure
Secondary outcome measures
Cognition Disorders
Change in Color Vision
Change in Composite Memory
+3 more
Other outcome measures
Changes in National Eye Institute Visual Functioning Questionnaire - 25 (VFQ-25)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: VisionPure Dietary SupplementExperimental Treatment1 Intervention
One dose (2 softgel capsules) will be consumed once daily for 60 days. A single dose contains: 976mg fish oil (120mg eicosapentaenoic acid, 610 mg docosahexaenoic acid), 20mg lutein, 4mg zeaxanthin isomers, 25mcg vitamin D3.
Group II: PlaceboPlacebo Group1 Intervention
One dose (2 softgel capsules) will be consumed once daily for 60 days. A single dose contains: 727mg organic sunflower oil, 15mg organic lemon essential oil, 1.5mg vitamin E T-70, 0.7mg natural fish flavor.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
VisionPure Dietary Supplement
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Applied Science & Performance InstituteLead Sponsor
11 Previous Clinical Trials
664 Total Patients Enrolled
True Eye Experts - New TampaUNKNOWN
1 Previous Clinical Trials
131 Total Patients Enrolled
Jacob Wilson, Ph.D.Principal InvestigatorThe Applied Science and Performance Institute
1 Previous Clinical Trials
76 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there open spots available for the trial currently?

"According to information found on clinicaltrials.gov, this research is currently enrolling interested individuals. It was initially published on August 1st 2022 and the most recent update occurred October 12th of the same year."

Answered by AI

Would I meet the qualifications for this research project?

"Only applicants with intact visual acuity, between 18 and 40 years of age are eligible for this research trial. As of now, 16 participants have been recruited."

Answered by AI

What is the scale of the research sample involved in this experiment?

"Affirmative. According to the clinicaltrials.gov portal, this medical trial, which was first advertised on August 1st 2022, is still open for recruitment. 16 individuals need to be drawn from 3 distinct healthcare facilities."

Answered by AI

What is the aim of this trial?

"According to the Applied Science & Performance Institute, which is sponsoring this study, there are two primary metrics of success - namely Change in Ganglion Cell Complex Thickness measured between Day 0 and 60. Additionally, secondary outcomes include but are not limited to: Change in Cognitive Attention (the capacity for multitasking); Change in Visual Memory (recognition/recall capability) and; Change in Color Vision (determined by Ishihara Plates)."

Answered by AI

Are octogenarians eligible to participate in the experiment?

"This medical trial welcomes patients aged 18 and below 40 to participate."

Answered by AI
~6 spots leftby Apr 2025